Jerman

Index
Globenewswire

LEAG and Fluence to Build the Largest Battery Storage Project in Europe with a Capacity of 4 GWh

Globenewswire

Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases

Globenewswire

Boehringer Ingelheim Acquires License from Kyowa Kirin Aimed at Developing a Novel Treatment for Patients with Autoimmune Diseases

Globenewswire

ESPAS and Steinehelden Use Descartes’ Solution to Optimize Ecommerce Productivity by 500% While Supporting Special Needs of Workers

Globenewswire

RIB Software Partners with Microsoft to Accelerate AI in Construction

Globenewswire

JASCAYD® (nerandomilast) Approved in China for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Globenewswire

Boehringer’s Zongertinib Demonstrated a 77% Objective Response Rate in Treatment-naïve Patients with Advanced HER2 (ERBB2)-mutant NSCLC

Globenewswire

Boehringer Ingelheim Advances Cancer Antibody-drug Conjugate Portfolio with Asset from AimedBio

Globenewswire

From Diversity to Impact: The Power of Diversity Funding Facility Identifies Priority Opportunity Crops for Investment

Globenewswire

U.S. FDA Approves Boehringer’s JASCAYD® (nerandomilast tablets) as First New Treatment Option for Adults with IPF in Over a Decade

Globenewswire

Rentschler Biopharma Further Expands its Services in Japan and South Korea and will Attend BioProcess International Asia

Globenewswire

Automotive: BYD Marks Impressive Presence at IAA Mobility 2025 in Munich

Globenewswire

BYD’s Stella Li Highlights New Models, European Factory and Innovation at IAA Mobility 2025

Globenewswire

21X Rings the Bell as Trading Starts on the World’s First Blockchain-based Exchange for Tokenized Securities and Stablecoins

Globenewswire

Sportradar Strengthens Bundesliga International Relationship With Launch of Innovative New Products Starting 2025-26 Season

Globenewswire

Boehringer Ingelheim and Palatin Technologies to Develop Potential First-in-class Melanocortin Receptor Targeted Treatment for Patients with Retinal Diseases

Globenewswire

Boehringer and Click Therapeutics’ Investigational Prescription Digital Therapeutic CT-155 Meets Primary Endpoint in CONVOKE Study for Negative Symptoms in Schizophrenia

Globenewswire

SAP to Acquire SmartRecruiters: Integration of Innovative Talent Acquisition Portfolio Will Help Companies Attract and Retain Top Talent

Globenewswire

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Globenewswire

Boehringer Ingelheim and Re-Vana Therapeutics Announce Strategic Collaboration to Develop Long-Acting Ophthalmic Therapies

Globenewswire

Boehringer Ingelheim Initiates Phase II Study of BI 1815368, a Potential First-in-class Oral Treatment for Diabetic Macular Edema

Globenewswire

RIB Software Recognized as a Leader for Construction Management Software by Independent Research Firm

Globenewswire

AC Split Inverter Terbaru Midea Memenangkan Penghargaan Red Dot Jerman

Globenewswire

Boehringer Ingelheim and Eko Health Inc. Enter Digital Health Collaboration to Improve Heart Murmur Detection in Dogs

Globenewswire

Midea's Latest Inverter Split Air Conditioner Won the German Red Dot Award